Market Cap (In USD)
1.15 Billion
Revenue (In USD)
1.12 Billion
Net Income (In USD)
70.4 Million
Avg. Volume
422.97 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.925-21.48
- PE
- -
- EPS
- -
- Beta Value
- 0.936
- ISIN
- US29082K1051
- CUSIP
- 29082K105
- CIK
- 1872789
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Devdatt Kurdikar
- Employee Count
- -
- Website
- https://www.embecta.com
- Ipo Date
- 2022-03-22
- Details
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
More Stocks
-
OLAOrla Mining Ltd.
OLA
-
EDVREndeavor Bancorp
EDVR
-
SBFCSBFC Finance Limited
SBFC
-
CABGYCarlsberg A/S
CABGY
-
HWTHFWildsky Resources Inc.
HWTHF
-
026940Bookook Steel Co., Ltd.
026940
-
8070
-
LRDJFSt. James Gold Corp.
LRDJF